Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer

BACKGROUND: Cyclo-oxygenase-2 (COX-2), the key enzyme in the conversion of arachidonic acid to prostaglandins, is involved in critical steps of tumor onset and progression, and is a strong predictor of chemotherapy resistance and poor outcome in advanced ovarian cancer. To our knowledge, no data has...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrandina, Gabriella, Ranelletti, Franco O, Martinelli, Enrica, Paglia, Amelia, Zannoni, Gian Franco, Scambia, Giovanni
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1534059/
https://www.ncbi.nlm.nih.gov/pubmed/16831230
http://dx.doi.org/10.1186/1471-2407-6-182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1534059/
https://www.ncbi.nlm.nih.gov/pubmed/16831230
http://dx.doi.org/10.1186/1471-2407-6-182

Ejemplares similares